🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to learn how well a combination of iparomlimab...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Start Date
2026-10-01
Trial ID
NCT07776080
Study Design Prospective, single-arm, multicenter clinical study. Study Dr...
Status
Not Yet Recruiting
Location
Nanjing Drum Tower Hospital
Start Date
2026-08-15
Trial ID
NCT07741617
Treatments Being Tested
The primary objective is to evaluate the improvement in Objective Response ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07277972
Treatments Being Tested
The investigators plan to initiate a prospective, multicenter, phase II stu...
Status
Recruiting
Location
Nanjing Drum Tower Hospital
Start Date
2025-09-03
Trial ID
NCT07110064
Treatments Being Tested
This study will evaluate the efficacy and safety of cryoablation combined w...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2025-08-20
Trial ID
NCT07070700
Treatments Being Tested
Through the combination of aparolitovorelli monoclonal antibody and lenvati...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-11-21
Trial ID
NCT07389629
Treatments Being Tested
Efficacy and safety of Iparomlimab and Tuvonralimab in combination with len...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT07151209
Treatments Being Tested
Patients with salivary gland carcinoma were divided into groups according t...
Status
Recruiting
Location
Fei Ma
Start Date
2023-08-15
Trial ID
NCT06145308
Treatments Being Tested
The aim of this prospective, randomized, controlled clinical trial is to ev...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07738159
Treatments Being Tested
To evaluate the efficacy of Iparomlimab and Tuvonralimab in combination wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-24
Trial ID
NCT07150377
Treatments Being Tested